Thursday, June 4, 2026

IATA Updates Projected Revenue Loss to $314 Billion for Global Airlines

The International Air Transport Association (IATA) has issued a statement, addressing the current aircraft grounding worldwide and the resulting financial losses.

Due to maximized efforts to stop the spread of the coronavirus, aircraft around the world have been grounded, with only a small number of flights still going to limited destinations. As a result, heavy financial losses have ensued, and the IATA has issued a statement regarding the severity of the foregone revenue. In a previous statement, the IATA projected the total impact of coronavirus mitigation efforts to cost the airline industry approximately $252 billion, but has since revised that estimate to $314 billion.

Since January, flights have decreased by 80%, and the IATA is expecting the revenue from air travel ticket sales to decrease by 55% in the forthcoming year. The trade association is projecting to open domestic air travel by the third quarter 2020, but is cautioning against opening air travel at the international level. IATA’s CEO issued a statement, calling on governments to turn their attention towards the airline industry and begin putting plans in place to reopen economies as a move to restore air travel consumer confidence.

Information for this briefing was found via the International Air Transport Association. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

SSR Mining Walks Away From a World Class Gold-Copper Project

Why More Canadians Are Starting to Think About Leaving | Jesse Day

Instead of Waiting, This Gold Developer Went Bigger | Kenneth McLeod – Sonoro Gold

Recommended

Amid CBS Shuffle, Is Joe Rogan Replacing Anderson Cooper On 60 Minutes?

Silver47 Targets Resource Growth With 10,000 Metre Red Mountain Drill Program

Related News

Revive Therapeutics Granted FDA Approval For Phase 3 Clinical Trial For Bucillamine In COVID-19 Treatment

It’s a big day for Revive Therapeutics (CSE: RVV) (OTC: RVVTF). The company announced this...

Friday, July 31, 2020, 09:16:29 AM

Meat Processing Plants Turning to Robot Butchers to Reduce Coronavirus Infection Rates Among Workers

As the coronavirus pandemic continues to sweep across the US with record breaking infection rates,...

Sunday, July 12, 2020, 03:01:00 PM

Kontrol Energy Finally Releases Some Data On BioCloud Detection Limits

Well after a month following the initial release of “positive lab results for COVID-19 testing,”...

Thursday, October 29, 2020, 09:06:50 AM

Alamos Gold Suspends Operations At Island Gold Mine

Alamos Gold (TSX: AGI) announced this morning that it would be suspending its operations at...

Tuesday, March 24, 2020, 09:24:20 AM

California Governor Calls on Congress to Issue Additional $1 Trillion for Local Governments

As if the Democrat’s $3 trillion coronavirus relief bill isn’t enough to make the Republican...

Wednesday, May 20, 2020, 05:31:00 PM